The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

Eph Receptors and Ephrin Signaling Pathways: A Role in Bone Homeostasis

(2012) Claire M. Edwards et al.   International Journal of Medical Sciences

Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade

(2009) S. Yamanda et al.   BLOOD

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease

(2009) Angela Pennisi et al.   BRITISH JOURNAL OF HAEMATOLOGY

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

(2008) Angela Pennisi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Modulation of ephrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferation

(2008) Agneta Månsson-Broberg et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Role of decorin in the antimyeloma effects of osteoblasts

(2008) X. Li et al.   BLOOD

Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth

(2008) Y.-W. Qiang et al.   BLOOD

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

(2008) Y.-W. Qiang et al.   BLOOD

Eph-Ephrin Bidirectional Signaling in Physiology and Disease

(2008) Elena B. Pasquale   CELL

EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts

(2008) Elizabeth H Allan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The cell biology of bone metabolism

(2008) H K Datta et al.   JOURNAL OF CLINICAL PATHOLOGY